Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

NOTE’s Interim Report January–March 2018

Financial performance January–March• Sales increased by 11% to SEK 308.0 (277.1) million.• Operating profit amounted to SEK 16.8 (30.4) million, and adjusted for non-recurring items in the first quarter of the previous year of SEK +15.7 million net, operating profit increased to SEK 16.8 (14.7) million.• Operating margin was 5.5% (11.0%). Adjusted for non-recurring items in the first quarter of the previous year, operating margin expanded by 0.2 percentage points to 5.5% (5.3%).• Profit after financial items was SEK 15.0 (29.1) million.• Profit after tax of SEK 12.3 (26.9) million,

Data from the MIV-711 initial phase IIa study will be presented at the OARSI World Congress on April 27

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today informs that data from the initial phase IIa study of MIV-711, which demonstrated disease-modifying activity in patients with moderate knee osteoarthritis after only six months of treatment, will be presented during the Osteoarthritis Research Society International (OARSI) World Congress, which will take place from 26-29 April 2018 in Liverpool, UK. The oral presentation will be given by the study’s lead investigator Dr. Philip Conaghan, Professor of Musculoskeletal Medicine at the University of Leeds in the UK, as indicated

Interim report January to March 2018

Press release, Sweden, Stockholm, April 26, 2018 TagMaster grows at good pace First quarter · Net sales increased during the first quarter by 35,5% to 57,0 MSEK (42,1) · Result before depreciation (EBITDA) increased during the first quarter by 9,3% to 5,3 MSEK (4,8), corresponding to a margin of 9,2% (11,4) · Net result after tax was 2,9 MSEK (3,1) · Result per share was 0,01 (0,02) · Cash flow from the business for the period was -3,2 MSEK (7,3) Comments by the CEO The TagMaster Group has continued to grow in good speed (35,5%) during the first quarter. Our

Enzymatica AB: Continued growth during the first quarter

Interim report forEnzymatica AB (publ)                                                                                                                                                                                  JANUARY- MARCH 2018Continued growth during the first quarter First quarter                          · Net sales reached SEK 15.1 (9.6) million. · Net profit after tax came in at SEK -10.1 (-11.4) million. · Earnings per share, basic and diluted, were SEK -0.11(-0.13). · Cash and cash equivalents were SEK 8.2 (26.0) million. Significant events during

C-RAD AB – Interim report January-March 2018

CONTINUED STRONG GROWTH, REVENUE INCREASED BY 31 PERCENT JANUARY - MARCH 2018                                                    · Order intake: 50.6 (40.2) MSEK, 26%. · Revenues: 33.8 (25.8) MSEK, 31%. · Operating profit: -4.7 (-5.7) MSEK. · Net results after tax: -4.9 (-5.8) · Result per share: -0.16 (-0.20) SEK. · Order for GEMini Portal Imaging Detector from HGPT Beijing Technology & trade Co. Ltd., order value 1.5 MSEK. · Order from Varian Medical Systems regarding equipment for Nya Karolinska Solna, Sweden, additional order value 6,7 MSEK. · Order of

Nokian Tyres: Disclosure under chapter 9, section 10 of the securities market act

Nokian Tyres plc Stock Exchange Release April 26, 2018, at 9:20 a.m. Nokian Tyres has received an announcement from BlackRock, Inc. on April 25, 2018, in accordance with the Finnish Securities Market Act Chapter 9, Section 5. According to the announcement, the total number of Nokian Tyres shares owned by BlackRock, Inc. and its funds exceeded level of 5% of the share capital in Nokian Tyres plc, as a result of share transactions concluded on April 24, 2018. BlackRock, Inc. and its funds held on deal date a total of 6,957,816 Nokian Tyres’ shares representing 5.06% of company’s 137,277,

CMP and Mercedes-Benz Försäljnings AB extend collaboration

Mercedes-Benz Försäljnings AB is establishing a base in the port area in Malmö and thereby strengthening its collaboration with CMP. The company previously rented outdoor areas from CMP, but it has now decided to move its workshop operation to Frihamnen.CMP and Mercedes-Benz Försäljnings AB concluded a service and rental agreement for 6,000 m2 of outdoor areas back in 2017. This relationship is now being enhanced as Mercedes-Benz Försäljnings AB is moving part of its workshop operation for delivery service from Fosie to CMP at Frihamnen in Malmö. This provides Mercedes-Benz with better

UPM Paper ENA to be renamed UPM Communication Papers

(UPM, Helsinki, 26 April 2018 at 09:15 EET) - UPM Paper Europe and North America (ENA) business area will be renamed UPM Communication Papers as of 26 April 2018. The new name underlines the industry focus and global reach of the business area. It further highlights UPM's long-term commitment to sustaining its global graphic paper business, building on the view that paper will continue to be an important part of the media mix in the publishing industries and business communication. UPM Communication Papers is a world leading producer of graphic papers, offering an extensive product range

Report from Annual General Meeting in SyntheticMR AB 2018

The Annual General Meeting (AGM) of SyntheticMR AB (publ) was held on April 25, 2018, whereby the meeting resolved in accordance with the Board's proposed resolutions. The full resolutions are stated in the notice of the meeting.During his presentation at the Annual General Meeting, CEO Stefan Tell talked about, among other things, developments in 2017 and the first quarter of 2018. "2017 was another year of strong growth and further development of our partnerships. Sales of MAGiC via GE Healthcare developed well and important steps were taken to make MAGiC functionality available in the

DDM nominates Torgny Hellström as Chairman of the Board

DDM Holding AG (First North: DDM) announces the nomination of Torgny Hellström as Chairman of the Board. Torgny Hellström is currently a member of the Board of Directors of DDM Holding AG, and has been selected to succeed Kent Hansson, who has declined re-election as Chairman. “The Board wishes to thank Kent Hansson for his significant contributions to our company. With Torgny Hellström, DDM will get an experienced Chairman who knows our business well,” says Joachim Cato, Chairman of the Nomination Committee of DDM Holding AG. Kent Hansson will remain in his position as interim CEO of

AQ Group AB (publ), interim report January - March, 2018

First quarter, January – March 2018 in brief · Continued good growth, but improvement work is still required concerning margins and cash flow · Net sales increased by 8.8 % to SEK 1 090 million (1 002) · Operating profit (EBIT) decreased by 17.6 % to SEK 72 million (87) · Profit after financial items (EBT) decreased by 25.8 % to SEK 68 million (92) · Profit margin before tax (EBT %) was 6.3 % (9.2) · Cash flow from operating activities increased by 129 % to SEK 35 million (15) · Equity ratio 61 % (60) · Earnings per share after tax decreased by 25.3 % to SEK 3.13

Attendo's first quarter report 2018 to be published on 4 May - Invitation to teleconference

On 4 May 2018, around 08:00 am (CET), Attendo will present its first quarter results of 2018. Investors, analysts and journalists are hereby invited to participate in a teleconference at 10:00 am (CET) on the same date.The teleconference will be hosted by Attendo’s acting CEO Pertti Karjalainen and CFO Fredrik Lagercrantz. The presentation will be held in English. Date:             4 May 2018Time:             10:00 am (CET) To participate in the conference, please dial in on any number below at least ten minutes before the start of the call: SE:                +46 8 50 55 64 53

Bonava’s board of directors has resolved to repurchase own shares of series B

Based on the authorisation granted by the annual general meeting on 25 April 2018, the board of directors of Bonava AB (publ) (”Bonava”) has resolved to repurchase own shares of series B.The purpose of the authorisation to repurchase shares, and the board of directors’ resolution to utilise it, is to secure costs (including costs for social security costs) and delivery of shares for the implementation of Bonava's, from time to time outstanding, incentive plans. Repurchases of own shares of series B will be carried out in accordance with Nasdaq's Rule book for Issuers. The repurchases

A good start to the year

First quarter · Net sales increased by 2% to SEK 18,550 M (18,142), with organic growth of 4% (6) and acquired net growth of 2% (3) · Strong growth was shown by Global Technologies and Entrance Systems and good growth by Asia Pacific, EMEA and Americas · Operating income (EBIT) increased by 2% and amounted to SEK 2,829 M (2,787), corresponding to an operating margin of 15.3% (15.4) · Net income amounted to SEK 1,964 M (1,918) · Earnings per share amounted to SEK 1.77 (1.73) · Operating cash flow amounted to SEK 575 M (824). Sales and income +------------------------

Interim Report January – March 2018

Continued progress of the project portfolio  January - March 2018 · Net sales for the period amounted to SEK 52.3 million (26.2)  · Operating profit amounted to SEK 18.9 million (1.5)  · Profit for the period amounted to SEK 15.4 million (1.1)  · Earnings per share were SEK 0.18 (0.02)  · Cash flow from operating activities amounted to SEK -42.0 million (-38.4)  Key events during the period January – March 2018 · BioArctic’s patent was granted in the US and Japan for treatment of patients with complete spinal cord injury with a medical device, which is one of the

REPORT ON THE FIRST QUARTER 2018

FIRST QUARTER · Net sales for the quarter totaled SEK 4,442 m (3,443); an increase of 29%, of which 10% organic, -2% currency translation and 21% M&A. · Operating profit (EBIT) amounted to SEK 638 m (418), an increase of 53% including SeaStar. This represents a margin of 14.4% (12.1%). Excluding SeaStar, EBIT increased by 26%. · There were no items affecting comparability in the quarter. · Cash flow for the quarter improved to SEK -116 m (-384). · Operating cash flow improved to SEK -27 m (-44). · Profit for the quarter increased with 27%, to SEK 375 m (296). ·

KARO PHARMA DOUBLES SALES AND EARNINGS IN THE FIRST QUARTER

INTERIM REPORT JANUARY – MARCH 2018 ·Net sales amounted to MSEK 267.1 (139.3), equivalent to an increase of 91.7%. Growth was mainly due to acquisitions. ·Organic growth was +10.7%, whereof pharmaceuticals +18.8% and other products +4% ·The gross margin was 56.8% (53.7%) for the period. ·EBITDA amounted to MSEK 88.7 (43.7), which corresponds to a margin of 33.3% (31.4%) ·Earnings per share was SEK 0.45 (0.27) ·Cash and other short-term investments amounted to MSEK 295.2 (166.1) at the end of the period. ·A rights issue to partly finance the

Invitation to Eltel’s first quarter 2018 interim report presentation

Eltel will publish its report for the first quarter 2018 on Friday 4 May 2018 at approximately 08.00 am CET. Eltel’s CEO Håkan Kirstein and CFO Petter Traaholt will host a presentation via audiocast in English starting at 10.00 am CET.The presentation will be audiocasted live on www.eltelgroup.com. For those who would like to participate in the telephone conference in connection with the presentation, the telephone numbers are: · SE: +46 8 566 427 00 · FI: +358 9 817 104 94 · UK: +44 20 300 898 13 Please, call well in advance to register. After the presentation, there will

MUNTERS FIRST QUARTER REPORT 2018

Solid organic net sales growthFirst quarter 2018 · Order intake decreased by 1% to SEKm 1,635 (1,654) and increased by 2% organically. No large order signed within Data Centers in the quarter. · Net sales increased by 5% to SEKm 1,601 (1,519) while the organic growth was 7%. · The order backlog increased by 26% to SEKm 2,516 (1,998). · Operating profit (EBIT) increased by 2% to SEKm 76 (75). · Adjusted EBITA decreased by 22% to SEKm 115 (147), corresponding to an adjusted EBITA margin of 7.2% (9.7). · Net income was SEKm 42 (-41). · Cash flow from operating activities

Sobi™ publishes the report for the first quarter 2018

Swedish Orphan Biovitrum AB (publ)  (Sobi™) today announces the results for the first quarter 2018. Total revenues grew 41 per cent compared to Q1 2017 and amounted to SEK 1,964 M. EBITA was SEK 771 M, an increase of 90 per cent and gross margin amounted to 72 per cent (74). 2018 off to a strong start · Total revenues of SEK 1,964 M (1,396) · 41 per cent sales growth in the quarter compared to Q1 2017(43 per cent at constant exchange rates, CER) · EBITA increased with 90 per cent to SEK 771 M (406) · Net cash position of SEK 1,744 M (1,472 as of 31

Interim Report Q1 2018

JANUARY 1 – MARCH 31, 2018(compared with the year-earlier period) · Net sales increased 11% to SEK 4,400m (3,972). Sales growth was mainly related to higher prices in the industrial units. · EBITDA rose 47% to SEK 1,175m (797). The improvement in EBITDA was mainly related to higher prices in Wood, Pulp and Kraftliner, and an improved market and product mix. · EBITDA margin increased to 26.7% (20.1) · Earnings per share amounted to SEK 1.00 (0.52) · Operating cash flow, which excludes strategic capital expenditures, rose to SEK 591m (85). Strategic capital expenditures

Interim Report Q1 2018

Zubsolv US growth of 26 percent in local currency Q1 2018 highlights · Total net revenues of SEK 139.7 million, up 9.7 percent from Q1 previous year · Zubsolv US net revenue of SEK 131.1 million, up 14.9 percent in SEK and 26.2 percent in local currency compared to the same period last year · EBITDA of SEK -16.6 million, in line with guidance · Cash flow from operating activities of SEK 106.0 million, building a cash balance of SEK 437.5 million · Pipeline update, two more projects disclosed · Earnings per share, before dilution SEK -0.75 (-1.00), earnings per share

Tobii AB Interim Report Q1 2018

Tobii AB today reported its results for the first quarter 2018. Comment by Tobii’s CEO Henrik Eskilsson: “We had a very favorable start to the new year across the board. Sales growth was exceptional for Tobii Pro and the behavioral research segment. For Tobii Dynavox, sales development was positive now that sales are taking off for the products launched in 2017. Most notable in Tobii Tech was the very strong momentum in VR.” First quarter 2018 · The Group's net sales increased to SEK 294 million (259), compared with the first quarter of 2017. Adjusted for currency effects, the

There are no items matching the current filter
There are no more items matching the current filter
Back to top